A ministerial decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law is meant to clear the way for the introduction of Epidyolex into the market, not to prevent consumer wellness products being sold ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.